Three-step conversion of protected taxane ester to paclitaxel

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6452025
SERIAL NO

09843235

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a method of producing paclitaxel from a protected coupled ester compound having a formula: ##STR1## wherein P.sub.1 is a hydrogenatable protecting group, comprising deprotecting the 7-O-position and 3'-N-position of the protected coupled ester compound to form a first intermediate compound, benzoylating the first intermediate compound at the 3'-N-position thereby to form a second intermediate compound, and deprotecting the second intermediate compound by replacing P.sub.1 with hydrogen in the presence of an acid. The present invention also provides chemical compounds useful in the production of paclitaxel.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MAYNE PHARMA (USA) INCMACK CALI CENTRE II 650 FROM ROAD 2ND FLOOR PARAMUS NJ 07652

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
McChesney, James D Boulder, CO 72 324
Zygmunt, Jan Longmont, CO 32 117

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation